Share  |    |    |    |
Please fill out the form below to tell your Member of Congress to help ease the burden of high out of pocket costs for families impacted by cancer by cosponsoring HR 1409 - The Cancer Drug Parity Act!
If you take action and have not already registered, you will receive periodic updates and communications from ZERO - The End of Prostate Cancer.
Cosponsor The Cancer Drug Parity Act
As an advocate for ZERO - The End of Prostate Cancer and as your constituent, I am respectfully writing to request your support S.741 or HR 1730, the Cancer Drug Parity Act to ensure that every cancer patient has access to the anti-cancer treatments recommended by their health care provider.As you know, cancer treatment can be a trying time for patients and their families. Traditionally, intravenous (IV) and injected treatments were the primary methods of chemotherapy delivery, which are covered under a health plan's medical benefit where the patient is traditionally only required to pay a small office visit co-pay. Today, oral anti-cancer medication has become more prevalent and is the standard of care for many types of cancer, including prostate cancer. Oral anti-cancer medication also accounts for approximately 35% of the oncology development pipeline. More importantly, many oral anti-cancer medications do not have IV or injected alternatives and are the only option for some cancer patients. As these medications become more prevalent in cancer treatment, they must be as affordable as their IV counterparts.
Sincerely,[Your Name] [Your Address] [City, State ZIP][Your Email]